Trinity Biotech | TRIB - Loan Capital


Trinity Biotech reported $114.86M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
EDAP TMS EUR 1.01M 13K Sep/2025
J&J USD 39.44B 30M Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 27.43B 966M Dec/2025
Siemens EUR 42.84B 2.01B Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Tosoh JPY 74.39B 22.26B Dec/2025
Trinity Biotech USD 114.86M 4.81M Sep/2025
Veracyte USD 0 0 Mar/2025